Nauset Wealth Management’s Kyntra Bio KYNB Stock Holding History

Nauset Wealth Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$12K	Buy	+40	New	+$13.9K	0.01%	192

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Nauset Wealth Management's KYNB Position: Q1 2022 in Review

Nauset Wealth Management opened a new position in Kyntra Bio (KYNB) in Q1 2022: 40 shares worth $12K. The stake represents 0.01% of the portfolio and ranks #192 among its holdings.

156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

Nauset Wealth Management held 40 shares of Kyntra Bio worth $12K as of Q1 2022.
Kyntra Bio was a new Nauset Wealth Management position in Q1 2022.
Kyntra Bio made up 0.01% of Nauset Wealth Management's portfolio in Q1 2022, its #192 holding.
156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Nauset Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.